Ocugen, Inc.
NASDAQ:OCGN · NASDAQ Capital Market
+$0.03 today
Vol 26.19M · Avg 7.51M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+26.39%
Period High
$2.48
Period Low
$0.92
Latest
$1.24
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alumis Inc. Common Stock
NASDAQ:ALMS
$2.85B
RAPT Therapeutics, Inc.
RAPT
$959.26M
Lexicon Pharmaceuticals, Inc.
NASDAQ:LXRX
$890.61M
Omeros Corporation
NASDAQ:OMER
$739.68M
Neurogene Inc.
NASDAQ:NGNE
$494.68M
Lineage Cell Therapeutics, Inc.
AMEX:LCTX
$304.14M
Compass Therapeutics, Inc.
NASDAQ:CMPX
$281.41M
Neumora Therapeutics, Inc. Common Stock
NASDAQ:NMRA
$271.16M
Fulcrum Therapeutics, Inc.
NASDAQ:FULC
$191.05M
ADC Therapeutics S.A.
NYSE:ADCT
$138.64M
What is the latest OCGN filing?
The latest filing shown is 4 dated Jun 17, 2026.
How many recent filings does OCGN have?
Intrinsic Alpha currently shows 20 recent filings for OCGN.
Explore More
Continue the stock analysis
Jump to another research area for this company.